Literature DB >> 22486521

Inhibitory effects of sigma-1 ligands on handling-induced tachycardia in conscious tethered rats.

Annie Delaunois1, Pierrette De Ron, Eric Detrait, Michel Guyaux.   

Abstract

We used conscious tethered Sprague-Dawley rats to evaluate the cardiovascular effects of four sigma-1 (σ1 ) agonists and five antagonists, given alone or in combination. All drugs were administered as a single intraperitoneal dose. The agonists were given at doses reported as efficacious in rodent cognition models, while the antagonists were administered at doses neutralizing agonist effects in vivo. Systolic blood pressure (SBP) and heart rate (HR) were continuously recorded for 20 min before and 60 min postadministration. Immediately after injection, a sudden, transitory increase in HR and SBP was noted in all animals, because of the stress induced by handling. For both parameters, a peak value (ΔHRmax and ΔSBPmax ) and an area under the curve of changes from baseline over the period 5-20 min postinjection (ΔHR_AUC5-20 min and ΔSBP_AUC5-20 min ) were calculated. Three of the four σ1 agonists (SKF-10,047, dehydroepiandrosterone (DHEAS), Compound 14) significantly reduced ΔHR_AUC5-20 min value without changing ΔHRmax , while the fourth one, SA-4503, had no significant effect. None of the antagonists (haloperidol, rimcazole, NE-100, and BD1047) reduced, and even one (progesterone) enhanced the stress-induced effects on HR. No changes in SBP were noted with any compound. When the antagonist NE-100 was administered just before SKF-10,047, it completely reversed the inhibitory effects of the σ1 agonist on HR increase. In conclusion, we demonstrated for the first time the involvement of σ1 receptors in the regulation of handling-induced tachycardia in the conscious rat. Although additional investigations are needed to fully understand this role, it might offer new therapeutic perspectives to σ1 ligands in the cardiovascular sphere.
© 2012 The Authors Fundamental and Clinical Pharmacology © 2012 Société Française de Pharmacologie et de Thérapeutique. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22486521     DOI: 10.1111/j.1472-8206.2012.01042.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  4 in total

1.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

2.  Sigma-1 receptor ligands improves ventricular repolarization-related ion remodeling in rats with major depression disorder.

Authors:  Yan Guo; Cui Zhang; Bo Shen; Bo Yang; Xiuhuan Chen; Xin Liu; Tianxin Ye; Yuhong Fo; Shaobo Shi; Chuan Qu; Jinjun Liang
Journal:  Psychopharmacology (Berl)       Date:  2020-11-02       Impact factor: 4.530

Review 3.  Sigmar1's Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology.

Authors:  Richa Aishwarya; Chowdhury S Abdullah; Mahboob Morshed; Naznin Sultana Remex; Md Shenuarin Bhuiyan
Journal:  Front Physiol       Date:  2021-07-07       Impact factor: 4.566

Review 4.  Is the sigma-1 receptor a potential pharmacological target for cardiac pathologies? A systematic review.

Authors:  Rebecca Lewis; Jiaqi Li; Peter J McCormick; Christopher L-H Huang; Kamalan Jeevaratnam
Journal:  Int J Cardiol Heart Vasc       Date:  2019-12-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.